<div id="div_question"><link href="style1.css" rel="stylesheet"/><b>Theme: </b>Interpretation of relative risk<br/><br/><table><tbody><tr><td><b>A.</b></td><td>Mirtazapine</td></tr><tr><td><b>B.</b></td><td>Venlafaxine</td></tr><tr><td><b>C.</b></td><td>Doxepin</td></tr><tr><td><b>D.</b></td><td>Fluoxetine</td></tr><tr><td><b>F.</b></td><td>8</td></tr><tr><td><b>G.</b></td><td>2</td></tr><tr><td><b>H.</b></td><td>3</td></tr><tr><td><b>I.</b></td><td>7</td></tr><tr><td><b>J.</b></td><td>10</td></tr></tbody></table><br/><br/>Consider the following study outlined below (Tiihonen, 2006 ).<br/><br/>Background: <br/><br/>It is unknown if antidepressant treatment is associated with either increased or decreased risk of suicide. <br/><br/>Objective: <br/><br/>To estimate the risk of suicide, attempted suicide, and overall mortality during antidepressant treatments in a real-life setting with high statistical power. <br/><br/>Method: <br/><br/>A cohort study in which all subjects without psychosis, hospitalized because of a suicide attempt from January 1, 1997, to December 31, 2003, in Finland, were followed up through a nationwide computerized database.  <br/><br/>Participants: A total of 15 390 patients with a mean follow-up of 3.4 years. <br/><br/>Main Outcome Measures: The propensity scoreadjusted relative risks (RRs) during monotherapy with the most frequently used antidepressants compared with no antidepressant treatment.<br/><br/>Results:<br/><br/>The risks of suicide associated with the use of each type of TCA, SSRI, and SNA vs no antidepressant use are shown below. <br/><br/><center><table><tbody><tr><td align="left" colspan="2"><a class="fancybox" data-fancybox="" href="https://d3a7z3xcyhqwt4.cloudfront.net/images_MRCPsychmentor/mmb023b.png" rel="group"><img class="ajaximage" src="https://d3a7z3xcyhqwt4.cloudfront.net/images_MRCPsychmentor/mmb023.png"/></a></td></tr><tr><td align="left" valign="top"></td><td align="right"><a class="fancybox lbmagglasslink" data-fancybox="" href="https://d3a7z3xcyhqwt4.cloudfront.net/images_MRCPsychmentor/mmb023b.png" rel="group"><img src="https://d3a7z3xcyhqwt4.cloudfront.net/css/images/mag_glass.png"/></a></td></tr></tbody></table></center><br/>Based on this information, answer the following questions below.<br/><br/><i>Tiihonen (2006) Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort. Arch Gen Psychiatry. 2006;63(12):1358-1367.</i> <br/><br/><table class="qbody" style="width:100%"><tbody><tr><td style="vertical-align: top;width:35px"><b>265.</b></td><td>Select the antidepressant that was associated with a significantly decreased risk of suicide. </td></tr><tr><td></td><td><b>Fluoxetine</b> Fluoxetine use was associated with significantly decreased risk. The boxs represent the ralative risk and the horizontal lines their 95% confidence intervals. Regarding fluoxetine, the box is to the left (indicating a RR of less than 1 so a reduced risk) and the confidence interval does not cross the line of no effect (therefore a significant result). </td></tr></tbody></table><br/><br/><table class="qbody" style="width:100%"><tbody><tr><td style="vertical-align: top;width:35px"><b>266.</b></td><td>Select the antidepressant that was associated with a significantly increased risk of suicide. </td></tr><tr><td></td><td><b>Venlafaxine</b> Venlafaxine use was associated with significantly increased risk. . The boxs represent the ralative risk and the horizontal lines their 95% confidence intervals. Regarding venlafaxine, the box is to the right (indicating a RR of greater than 1 so an increased risk) and the confidence interval does not cross the line of no effect (therefore a significant result).</td></tr></tbody></table><br/><br/><table class="qbody" style="width:100%"><tbody><tr><td style="vertical-align: top;width:35px"><b>267.</b></td><td>Select the number of individual antidepressants for which significant results were established. </td></tr><tr><td></td><td><b>2</b> Significant results were found for fluoxetine and venlafaxine.</td></tr></tbody></table><br/><br/></div>